Gen-Probe Aptima Assay for Chlamydia Trachomatis, Model 1199
Dna Probe, Nucleic Acid Amplification, Chlamydia. 510(k) K063451, from Gen-Probe, Inc. (San Diego, CA). Product code MKZ, class 1.
As of Nov 22, 2026, K063451 is an FDA 510(k) held by Gen-Probe, Inc., substantially equivalent on Jan 22, 2007 after 68 days, with no recalls tied to it in FDA's recall database.
- Review time: 68 days
- Recalls: 0
- Cited as a predicate by: 1 device
The GEN-PROBE APTIMA® Assay for Chlamydia trachomatis is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) to aid in the diagnosis of chlamydial urogenital disease using the TIGRIS® DTS® Automated Analyzer or semi-automated instrumentation as specified.
- Aptima® Chlamydia trachomatis AssayK230451 · Hologic, Inc. · Nov 16, 2023
- Aptima® Chlamydia trachomatis AssayK230451 · Hologic, Inc. · Nov 16, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 15, 2006
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3120
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files